Article
S113R mutation in SLC33A1 leads to neurodegeneration and augmented BMP signaling in a mouse model.
Disease models & mechanisms - 1 Jan 2017
Liu Pingting, Jiang Baichun, Ma Jian, Lin Pengfei, Zhang Yinshuai, Shao Changshun, Sun Wenjie, Gong Yaoqin
Abstract excerpt
The S113R mutation (c.339T>G) (MIM #603690.0001) in SLC33A1 (MIM #603690), an ER membrane acetyl-CoA transporter, has been previously identified in individuals with hereditary spastic paraplegia type 42 (SPG42; MIM #612539). SLC33A1 has also been shown to inhibit the bone morphogenetic protein (BMP) signaling pathway in zebrafish. To better understand the function of SLC33A1, we generated and characterized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
